🛡️Immunobiology Unit 1 – Immunobiology: Intro to Innate Immunity
Innate immunity is our body's first line of defense against pathogens. It includes physical barriers like skin, chemical barriers like enzymes, and cellular components like neutrophils and macrophages. These elements work together to provide rapid, non-specific protection within minutes to hours of exposure.
The innate immune system recognizes pathogens through pattern recognition receptors, triggering responses like phagocytosis and inflammation. It also activates the complement system and produces cytokines, setting the stage for adaptive immunity. Understanding innate immunity is crucial for developing new treatments for infections, inflammatory diseases, and cancer.
Innate immunity provides immediate, non-specific defense against pathogens and foreign substances
Comprises physical barriers (skin, mucous membranes), chemical barriers (enzymes, pH), and cellular components (neutrophils, macrophages, dendritic cells)
Pathogen-associated molecular patterns (PAMPs) are conserved molecular structures found on pathogens recognized by pattern recognition receptors (PRRs) on innate immune cells
Toll-like receptors (TLRs) are a major class of PRRs that detect various PAMPs and initiate innate immune responses
Complement system consists of plasma proteins that enhance phagocytosis, recruit inflammatory cells, and directly lyse pathogens
Three pathways of complement activation: classical, alternative, and lectin pathways
Cytokines are small signaling proteins secreted by immune cells that regulate immune responses (interleukins, interferons, tumor necrosis factors)
Chemokines are a subclass of cytokines that attract immune cells to sites of infection or inflammation
Components of the Innate Immune System
Physical barriers include skin, mucous membranes, and epithelial cells lining respiratory, gastrointestinal, and urogenital tracts
Skin provides a mechanical barrier and produces antimicrobial peptides (defensins, cathelicidins)
Mucous membranes secrete mucus that traps pathogens and contains antimicrobial enzymes (lysozyme)
Chemical barriers consist of enzymes (lysozyme, defensins), pH (acidic environment in stomach), and antimicrobial peptides
Cellular components include phagocytic cells (neutrophils, macrophages), dendritic cells, natural killer (NK) cells, and innate lymphoid cells (ILCs)
Humoral components include complement proteins, acute phase proteins (C-reactive protein), and cytokines
Innate immune system is evolutionarily ancient and found in all multicellular organisms
Provides rapid response to pathogens within minutes to hours of exposure
Cellular Players in Innate Immunity
Neutrophils are the most abundant white blood cells and first responders to infection
Phagocytose and kill pathogens through oxidative burst and release of granules containing antimicrobial enzymes
Macrophages are long-lived phagocytic cells that reside in tissues and engulf pathogens, debris, and apoptotic cells
Secrete cytokines and present antigens to T cells, linking innate and adaptive immunity
Dendritic cells are professional antigen-presenting cells that capture, process, and present antigens to T cells
Mature upon encountering pathogens and migrate to lymph nodes to initiate adaptive immune responses
Natural killer (NK) cells are cytotoxic lymphocytes that recognize and kill virus-infected and tumor cells
Secrete cytokines (interferon-gamma) that activate macrophages and enhance antiviral responses
Innate lymphoid cells (ILCs) are tissue-resident cells that secrete cytokines and regulate mucosal immunity
Three main subsets: ILC1 (produce interferon-gamma), ILC2 (produce IL-5 and IL-13), and ILC3 (produce IL-17 and IL-22)
Eosinophils and basophils are granulocytes involved in allergic reactions and defense against parasites
Mast cells are tissue-resident cells that release histamine and other mediators in allergic responses
PAMPs are conserved molecular structures essential for pathogen survival and absent in host cells (lipopolysaccharide, peptidoglycan, double-stranded RNA)
Toll-like receptors (TLRs) are a major class of PRRs expressed on cell surface or in endosomes
Different TLRs recognize specific PAMPs: TLR4 (lipopolysaccharide), TLR3 (double-stranded RNA), TLR9 (CpG DNA)
Other PRRs include C-type lectin receptors (CLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs)
PRR engagement activates signaling cascades that lead to production of cytokines, chemokines, and antimicrobial molecules
Innate immune cells also express receptors for opsonins (complement, antibodies) that enhance phagocytosis
Natural killer (NK) cells express activating and inhibitory receptors that regulate their cytotoxic activity
Activating receptors (NKG2D) recognize stress-induced ligands on infected or tumor cells
Inhibitory receptors (KIRs) recognize self MHC class I molecules and prevent NK cell activation
Innate Immune Responses
Phagocytosis is the process by which phagocytic cells (neutrophils, macrophages) engulf and destroy pathogens
Involves recognition of PAMPs or opsonized pathogens, actin polymerization, and formation of a phagosome
Phagosome fuses with lysosomes containing antimicrobial enzymes and reactive oxygen species
Neutrophils undergo oxidative burst, generating reactive oxygen species (superoxide, hydrogen peroxide) that kill pathogens
Neutrophils and other granulocytes release granules containing antimicrobial enzymes (myeloperoxidase, defensins) and proteases
Natural killer (NK) cells release cytotoxic granules containing perforin and granzymes that induce apoptosis in target cells
Innate immune cells secrete cytokines and chemokines that regulate immune responses and recruit additional immune cells
Macrophages and dendritic cells produce IL-1, IL-6, IL-12, and TNF-alpha
Neutrophils and epithelial cells produce IL-8, a potent neutrophil chemoattractant
Complement system enhances phagocytosis (opsonization), recruits inflammatory cells (anaphylatoxins), and directly lyses pathogens (membrane attack complex)
Interferons (type I and II) are cytokines that induce an antiviral state in infected and neighboring cells
Type I interferons (IFN-alpha, IFN-beta) are produced by most cells in response to viral infection
Type II interferon (IFN-gamma) is produced by NK cells and T cells and activates macrophages
Inflammation and Its Role
Inflammation is a protective response to infection, injury, or tissue damage that involves recruitment of immune cells and release of soluble mediators
Cardinal signs of inflammation: redness (rubor), heat (calor), swelling (tumor), pain (dolor), and loss of function (functio laesa)
Acute inflammation is a rapid, short-lived response that aims to eliminate the triggering stimulus and initiate tissue repair
Mediated by vasodilation, increased vascular permeability, and recruitment of neutrophils
Triggered by PAMPs, DAMPs (damage-associated molecular patterns), and pro-inflammatory cytokines (IL-1, TNF-alpha)
Chronic inflammation is a prolonged response that can lead to tissue damage and contribute to various diseases (atherosclerosis, cancer, autoimmunity)
Mediated by macrophages, lymphocytes, and fibroblasts
Characterized by simultaneous destruction and healing of tissue, formation of granulomas or tertiary lymphoid structures
Inflammatory mediators include cytokines (IL-1, IL-6, TNF-alpha), chemokines (IL-8), lipid mediators (prostaglandins, leukotrienes), and vasoactive amines (histamine)
Resolution of inflammation involves clearance of pathogens, apoptotic cells, and debris, followed by tissue repair and restoration of homeostasis
Mediated by specialized pro-resolving mediators (resolvins, protectins) and anti-inflammatory cytokines (IL-10, TGF-beta)
Dysregulated inflammation underlies many chronic diseases, making it a target for therapeutic intervention
Connection to Adaptive Immunity
Innate immune responses provide the first line of defense against pathogens and initiate adaptive immune responses
Dendritic cells are the key link between innate and adaptive immunity
Capture, process, and present antigens to naive T cells in lymph nodes
Provide costimulatory signals (CD80/86) and cytokines (IL-12) necessary for T cell activation and differentiation
Macrophages also present antigens to T cells and secrete cytokines that shape adaptive immune responses
M1 macrophages produce IL-12 and promote Th1 responses
M2 macrophages produce IL-10 and promote Th2 and regulatory T cell responses
Innate immune cells express cytokine receptors and respond to cytokines produced by T cells
IFN-gamma activates macrophages and enhances their microbicidal activity
IL-4 and IL-13 promote alternative activation of macrophages and wound healing
Innate lymphoid cells (ILCs) secrete cytokines that regulate T cell responses and maintain tissue homeostasis
ILC2s produce IL-5 and IL-13, which promote Th2 responses and allergic inflammation
ILC3s produce IL-17 and IL-22, which maintain intestinal barrier integrity and protect against extracellular bacteria
Adjuvants used in vaccines often stimulate innate immune responses (TLR agonists) to enhance adaptive immunity
Clinical Relevance and Applications
Defects in innate immunity can lead to increased susceptibility to infections
Neutropenia (low neutrophil count) is associated with bacterial and fungal infections
Chronic granulomatous disease (defective oxidative burst) leads to recurrent infections with catalase-positive bacteria and fungi
Excessive or dysregulated innate immune responses contribute to inflammatory and autoimmune diseases
Sepsis is a life-threatening condition caused by an overwhelming systemic inflammatory response to infection
Rheumatoid arthritis is characterized by chronic inflammation of synovial joints mediated by macrophages and fibroblasts
Targeting innate immune pathways is a promising strategy for treating inflammatory diseases and cancer
Monoclonal antibodies against TNF-alpha (infliximab) are used to treat rheumatoid arthritis and inflammatory bowel disease
Small molecule inhibitors of JAK kinases (tofacitinib) block cytokine signaling and are effective in treating rheumatoid arthritis and ulcerative colitis
Harnessing innate immunity is a goal of vaccine development and cancer immunotherapy
Adjuvants that stimulate TLRs (monophosphoryl lipid A) are used in vaccines to enhance immunogenicity
Chimeric antigen receptor (CAR) NK cells are being developed as an "off-the-shelf" cancer immunotherapy
Understanding the role of innate immunity in health and disease is crucial for developing new diagnostic tools and therapeutic interventions
Biomarkers of innate immune activation (C-reactive protein, IL-6) are used to monitor disease activity and response to treatment
Modulating the innate immune system holds promise for treating a wide range of diseases, from infections to cancer to autoimmunity